Globe Life (NYSE: GL) Raises 2026 Guidance After Q1 EPS Growth, Revenue In Line

NYSE: GL · April 22, 2026 · 3 min read

Globe Life Inc. (NYSE: GL) shares edged higher to $151.25 after the company reported first-quarter 2026 net income of $3.39 per diluted share — up 12.6% from $3.01 in the year-ago quarter — and raised its full-year profit guidance. Revenue of $1.56 billion rose 5.4% year over year, landing broadly in line with Wall Street expectations. The results were confirmed in an 8-K filing with the SEC on April 22, 2026.

Q1 2026 At a Glance

• Net income: $3.39 per diluted share vs. $3.01 in Q1 2025
• Net operating income: $3.43 per diluted share vs. $3.07 in Q1 2025
• Revenue: $1.56 billion, up 5.4% year over year
• Full-year 2026 earnings guidance: Raised (range not specified in available disclosures)
• Trailing P/E: 10.7x | Forward P/E: 9.1x
• Net margin: 19.4% | Operating margin: 24.2%
• Earnings growth (YoY): 9.5% | Revenue growth (YoY): 3.6%
• 52-week range: $111.13 – $152.80; stock last at $151.25

What Drove the Results

Strong underwriting performance was the primary engine behind the quarter's profit improvement, according to reporting from multiple news sources. Globe Life cited healthy demand for life and supplemental health insurance products as a key contributor, with underwriting discipline helping to widen margins even as top-line growth remained moderate.

At the operating level, the results reflect a business generating consistent profitability: a 24.2% operating margin and a 19.4% net margin underscore the company's cost efficiency relative to peers. Earnings per share growth of 9.5% year over year — running well ahead of the 3.6% revenue growth rate — suggests that margin improvement and share count management are doing meaningful work at the bottom line.

Wall Street View

Analyst sentiment toward Globe Life (NYSE: GL) has strengthened modestly in recent months. As of April 2026, the consensus stands at 4 Strong Buy, 14 Buy, and 4 Hold ratings, with zero Sell or Strong Sell recommendations. That compares with 4 Strong Buy, 12 Buy, and 4 Hold recorded in the prior month, reflecting two analysts upgrading their stance to Buy. The absence of any bearish ratings points to broad confidence in the company's earnings trajectory and updated guidance.

Investor Takeaway

Globe Life (NYSE: GL) enters the remainder of 2026 with raised guidance, a double-digit improvement in per-share earnings, and a forward valuation of 9.1x earnings that remains undemanding relative to the profit growth being delivered. The broad Buy consensus on Wall Street, reinforced by the guidance increase, suggests analysts view the company's underwriting discipline and insurance demand trends as durable. Investors monitoring the stock will note it is trading near the top of its $111.13 – $152.80 52-week range, reflecting the improving fundamental backdrop.